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Protein based therapeutics have emerged as a successful class of pharmaceutical. However, it is well known 
that much of the current therapeutic protein discovery and development processes is based around existing 
molecular frameworks and that novel formats offer significant challenges for expression. Efficient production of 
protein is required to meet the growing demands and increasing expectation of the patients and healthcare 
providers. Major obstacles during biopharmaceutical production are linked to the efficiency of the protein 
expression system and the biophysical properties of proteinbased products that can lead to aggregation and 
subsequent problems for purification, quality and effectiveness. Computational tools have been developed to aid 
prediction of protein solubility and aggregation propensity to support enhanced certainty of optimal generation of 
product with desirable properties. In this study, we have used an in-house computational tool for prediction of 
soluble protein expression (developed around protein structure and surface electrostatic properties of human 
erythropoietin, HuEPO) was developed in E. coli and has been validated experimentally with several 
bacteriallyexpressed model protein variants. The application of the computational approach has been extended 
to mammalian expression platforms. A significant inverse correlation was observed between positive surface 
patches and the expressability of HuEPO in transient mammalian cells (HEK and CHO cell lines). 
Mechanistically the differential expression operates at a level post-transcriptionally, associated with ribosome-
secretory complex engagement, protein stability or secretory processes. The results demonstrate the potential 
of application of a predictive computational algorithm as a design tool in rational protein engineering to improve 
expression of novel protein formats in mammalian systems as well as E.coli. In summary, optimization of 
molecular patches on the surface of proteins may be a viable strategy to enhance protein soluble expression 
and therefore a potential solution for development of novel proteins that might otherwise fit into the category of 
“difficult-toexpress” proteins.   
  
